The 20 Best Megalencephalic Leukoencephalopathy with Subcortical Cysts Doctors Near Me in Ann Arbor, MI

Ayesha Ahmad is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Ahmad is rated as an Advanced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 50 other conditions, according to our data. Her clinical expertise encompasses Pompe Disease, Propionic Acidemia, Von Gierke Disease, and Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome). Dr. Ahmad is board certified in Clinical Biochemical Genetics and Clinical Genetics & Genomics.

Shane Quinonez is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Quinonez is rated as an Advanced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. He is also highly rated in 129 other conditions, according to our data. His clinical expertise encompasses Pompe Disease, Dihydrolipoamide Dehydrogenase Deficiency, MELAS Syndrome, and Maple Syrup Urine Disease. Dr. Quinonez is board certified in Pediatrics, Clinical Biochemical Genetics, and Clinical Genetics & Genomics.

John K. Fink, MD, is a professor in the Department of Neurology and director of the Neurogenetic Disorders Program in the University of Michigan Medical School. He directs basic science laboratory research focused on identifying genes and mechanisms responsible for age-dependent neurologic degeneration; and on developing treatments for these conditions.Fink's laboratory investigates the molecular basis of inherited neurologic and psychiatric disorders. His clinical expertise focuses on inherited and degenerative disorders of the nervous system. Dr. Fink evaluates individuals of all ages, from infancy through senescence with these disorders, which include lysosomal storage disorders (such as Gaucher disease, Niemann-Pick disease and Fabry disease), ataxias (including Friedreich's ataxia), leukodystrophies (such as Krabbe, CADASIL and adrenoleukodystrophy), familial dystonia, primary lateral sclerosis, Wilson's disease, familial motor neuron disease (including familial amyotrophic lateral sclerosis), familial dementia, and a group of inherited spinal cord disorders known collectively as the Hereditary Spastic Paraplegias (HSPs).Dr. Fink came to the University of Michigan in 1990 as an assistant professor of neurology and director of the Neurogenetic Disorders Clinic. The program provides care and evaluation for individuals and families with inherited and degenerative neurologic disorders; and clinical and molecular laboratory training for physicians and scientists studying these disorders. He was promoted to associate professor in 1996 and professor in 2005.Board-certified in neurology and medical genetics, Dr. Fink received his medical degree in 1980 from the Medical College of Ohio in Toledo. Following internship at the Mayo Clinic in Rochester, Minnesota, he completed a neurology residency in 1984 at the University of Virginia in Charlottesville. Subsequently, he trained in developmental and metabolic neurology and medical genetics at the National Institutes of Health.Dr. Fink has served as the Medical Advisor to the Spastic Paraplegia Foundation since its establishment (2002), and serves as ad hoc reviewer for numerous journals and NIH study sections.A member of the American Society of Human Genetics, American Academy of Neurology, American Neurological Association and the American College of Genetics, Dr. Fink received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2002. In addition, he has been elected by peers to Best Doctors in America annually since 2001. Dr. Fink is rated as an Advanced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Spastic Paraplegia Type 2, Primary Lateral Sclerosis, and CACH Syndrome. Dr. Fink is board certified in Clinical Genetics and Neurology.

Cooking, spending time with my family. Dr. Ames is rated as an Advanced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 115 other conditions, according to our data. Her clinical expertise encompasses Delayed Growth, Cardiomyopathic Lentiginosis, Cardiofaciocutaneous Syndrome, and Noonan Syndrome. Dr. Ames is board certified in Pediatrics, Clinical Genetics & Genomics, and Medical Biochemical Genetics.

Dr. Lee earned her M.D. from Ross University School of Medicine in 2013, and completed Pediatric Residency at Ascension St. John Hospital in Grosse Point, MI, where she served as a Chief Pediatric Resident during her final year of residency. She completed Categorical Medical Genetics Residency at the University of Michigan in 2019. Following this she accepted a dual faculty position as a Clinical Lecturer in the Department of Pediatrics and Department of Internal Medicine for one year, before returning to Fellowship in 2020 to complete additional dedicated training in Medical Biochemical Genetics. After completion of Medical Biochemical Genetics Fellowship, she resumed her faculty position as a Clinical Assistant Professor in 2021. She is board certified in Pediatrics, and in Clinical and General Genetics.She has a dual faculty appointment in the Department of Pediatrics and the Department of Internal Medicine. As a faculty member in the Department of Pediatrics, she sees patients in the Pediatric Genetics and Biochemical Genetics Clinics, in addition to the newly created Multidisciplinary Genetics of Hearing Loss Clinic. As a faculty member in the Department of Internal Medicine, she sees patients in the Adult Medical Genetics and Cancer Genetics Clinics, in addition to patients with atypical diabetes and/or lipodystrophy in collaboration with MEND.In addition to her clinical responsibilities, Dr. Lee also enjoys spending time teaching and discussing various aspects of genetics with fellows, pediatric residents, medical students, and genetic counseling students. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 138 other conditions, according to our data. Her clinical expertise encompasses Biotinidase Deficiency, Delayed Growth, Beta-Ketothiolase Deficiency, and Triple X Syndrome. Dr. Lee is board certified in Pediatrics, Clinical Genetics & Genomics, and Medical Biochemical Genetics.

Dr. Pritchard is a Michigan native who returned to the University of Michigan to join the faculty here in 2019 after completing her pediatrics and genetics residencies and biochemical genetics fellowship. She enjoys care of complex patients with rare genetic diseases. Dr. Pritchard is active in medical education as Program Director for the Medical Biochemical Genetics Fellowship program and Associate Program Director for the Medical Genetics and Genomics training programs.Outside of work, Dr. Pritchard enjoys cooking, reading, hiking, and spending time with her husband and two daughters. Dr. Pritchard is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 149 other conditions, according to our data. Her clinical expertise encompasses Microcephaly Deafness Syndrome, Propionic Acidemia, Delayed Growth, and Cohen Syndrome.

Mark Hannibal is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Hannibal is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. He is also highly rated in 166 other conditions, according to our data. His clinical expertise encompasses Aase Syndrome, CHARGE Syndrome, Cockayne Syndrome Type 2, and Hennekam Syndrome. Dr. Hannibal is board certified in Clinical Genetics & Genomics.

Martha Carlson is a Pediatrics specialist and a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Carlson is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 41 other conditions, according to our data. Her clinical expertise encompasses Autism Spectrum Disorder, Seizures, Stereotypic Movement Disorder, and Spasmus Nutans.

Erin Knierbein is a Neuromusculoskeletal Medicine specialist and a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Knierbein is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 125 other conditions, according to our data. Her clinical expertise encompasses Danon Disease, Pompe Disease, Dysferlinopathy, and Duchenne Muscular Dystrophy. Dr. Knierbein is board certified in Neurology W/Spec Qual Child Neuro and Neuromuscular Medicine.

Dr. Elafros graduated Phi Beta Kappa and with honors from Michigan State University in Human Biology and Spanish before completing a Masters of Arts in Bioethics. She then received her MD degree and PhD in Epidemiology from Michigan State University during which time she lived in Zambia for two years to complete her doctoral dissertation which examined the medical and psychosocial burden of HIV and epilepsy among adults in the capital city Lusaka. Dr. Elafros then completed a neurology residency at Johns Hopkins Hospitals, during which time she received an R25 from the National Institutes of Health which allowed her to return to Zambia to examine barriers to care for patients with meningitis. She then joined the University of Michigan for neuromuscular fellowship in 2020.Dr. Elafros provides longitudinal patient care through the outpatient neuromuscular clinic at the University of Michigan. Dr. Elafros is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Diabetic Neuropathy, Myasthenia Gravis, and Seizures. Dr. Elafros is board certified in Neurology and Electrodiagnostic Medicine.

Zach London, M.D. is a Professor in the University of Michigan Medical School. Dr. London grew up in Milwaukee, Wisconsin. He graduated Magna Cum Laude from Brown University in 1997. He attended medical school at the University of Wisconsin – Madison, graduating in 2001. He completed a Preliminary Medicine Internship at St. Joseph Mercy Hospital in Ann Arbor in 2001, followed by Neurology Residency at the University of Michigan. After graduation from residency, he did a one-year fellowship in Clinical Neurophysiology/EMG at the University of Michigan.He joined the University of Michigan faculty as a neuromuscular neurologist in 2006, and has served as Program Director of the neurology residency program. Dr. London’s scholarly focus is the development of interactive educational tools, with a focus on educational boardgames. He is the founder of Neurd Games, which includes popular titles such as The Lesion: Charcot’s Tournament, The Plexus, Endowed Chairs: Neurology, Formaina, and Field Cut. He also created EMG Whiz, a popular web-based EMG training simulator, and mobile applications to teach the tenets of neuroanatomic localization.He has published online learning modules for the American Academy of Neurology and other national organizations, in addition to traditional publishing research regarding medical education and electrodiagnostic studies.Dr. London has been recognized with numerous national teaching awards, including the American Academy of Neurology (AAN) A.B. Baker Lifetime Achievement Award in Neurologic Education in 2023, The American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Innovation Award in 2021, and the American Neurological Association (ANA) Distinguished Teacher Award in 2017. At the University of Michigan, he received the 2013 Silver Shovel Award, the Provost’s Teaching Innovation Prize in 2015, and, in 2017, the Kaiser Permanente Award. Departmental honors include the Status Pedagogicus Award in 2008, and the James Albers Collegiate Professorship in 2018. He has been an honorary member of the GALENS medical society most years since 2011. Dr. London regularly speaks at national meetings on topics of medical education, game development, and clinical neurophysiology. He has served as chair or member of committees and workgroups for the AAN, ANA, AANEM, and ACGME, including serving as the Chair of the Consortium of Neurology Program Directors.Outside his work, Zach London is a founding board member of the Penny Seats Theatre Company in Ann Arbor. He has also composed and released one original song every month since 1993, posting them on his personal website www.hardtaco.org. Dr. London is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyneuropathy, and Chronic Polyradiculoneuritis. Dr. London is board certified in Neuromuscular Medicine, Neurology, and Electrodiagnostic Medicine.

Five children. Enjoys fitness, reading and spending time with family. Dr. Brophy is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Hemophilic Arthropathy, and Hemophilia A.

Tomoyasu Higashimoto is a Medical Genetics specialist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Higashimoto is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. He is also highly rated in 110 other conditions, according to our data. His clinical expertise encompasses Nevoid Basal Cell Carcinoma Syndrome, Methylmalonic Acidemia, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, and Propionic Acidemia. Dr. Higashimoto is board certified in Family Medicine and Clinical Genetics & Genomics.

Vikram Shakkottai is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Shakkottai is rated as an Advanced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 1, and Drug Induced Dyskinesia.

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.

Peter K. Todd, M.D., Ph.D., is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Todd earned his Bachelor of Science degree in 1994 from the University of California, San Diego. He then entered the Medical Science Training Program at the University of Wisconsin at Madison, where he completed his doctorate in 2002 and medical degree in 2004. His Ph.D research focused on synaptic defects in Fragile X Syndrome, a common inherited cause of cognitive impairment in children.He completed his internship and residency at the Hospital of the University of Pennsylvania in Philadelphia. While there, he did research on the role of the ubiquitin proteasome system and autophagy in Spinal and Bulbar Muscular Atrophy, a polyglutamine disorder, and Fragile X Tremor Ataxia Syndrome (FXTAS). He came to the U-M in 2008 for a clinical and research fellowship in movement disorders and neurogenetics.Todd joined the U-M faculty in 2010 as an assistant professor in movement disorders and neurogenetics, working in the laboratory of Henry L. Paulson, M.D., Ph.D., in the Center for Neurodegenerative Research.His current research is focused on the mechanisms underlying RNA-mediated neurodegeneration in FXTAS and myotonic dystrophy, and how these mechanisms may overlap and inform our understanding of other neurodegenerative disorders. He also sees patients with movement disorders and inherited neurological disease.Dr. Todd has received several academic awards, including a Howard Hughes Undergraduate Research Fellowship, the Francis M. Forester Prize for promise as an academic neurologist, the Samuel Ziritzky Prize for most outstanding research by a neurology resident at Penn and prizes for excellence in research at the International Conference on Unstable Microsatellites in Human Disease, and the U-M neuroscience day. Most recently, Dr Todd received the S. Weir Mitchell Alliance award from the American Academy of Neurology which each year recognizes one early investigator physician scientist who has made important contributions to basic science in neurological disorders.A member of the American Medical Association and the American Academy of Neurology, he has served as an ad-hoc reviewer for the Journal of Biological Chemistry, Neurology, Proceedings of the National Academy of Sciences, Neuron, Science and Human Molecular Genetics.His bibliography includes several peer-reviewed papers, editorials, book reviews and chapters, abstracts and online. Dr. Todd is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Fragile X Syndrome, Fragile XE Syndrome, Hereditary Ataxia, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Todd is board certified in Neurology.

Kara J. Wyant, MD, is a clinical lecturer in the Department of Neurology. She received her bachelor’s degrees in mathematics and music from Ohio Northern University, and medical degree from the University of Toledo College of Medicine. Dr. Wyant completed her neurology residency training at the University of Pittsburgh Medical Center, where she served as chief resident from 2015-2016. She is currently pursuing a fellowship in movement disorders at the University of Michigan focusing on the medical and surgical management of patients with Parkinson disease and parkinsonism. Dr. Wyant also serves on the neurohospitalist service at University Hospital, and participates in teleneurology consults for MidMichigan Health. Dr. (md) is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Drug Induced Dyskinesia, Parkinson's Disease, Movement Disorders, Dopa-Responsive Dystonia, and Deep Brain Stimulation. Dr. (md) is board certified in Neurology.

Christina Sloan is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Sloan is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 115 other conditions, according to our data. Her clinical expertise encompasses Chromosome 6q Duplication, Chromosome 8p Deletion, Delayed Growth, and Fragile XE Syndrome. Dr. Sloan is board certified in Medical Biochemical Genetics and Clinical Genetics & Genomics.

Amanda Kaufman is a primary care provider, practicing in Family Medicine in Ann Arbor, Michigan. Dr. Kaufman is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. Her clinical expertise encompasses Gaucher Disease, Gaucher Disease Type 2, Gaucher Disease Type 3, and Gaucher Disease Type 1.

Pamela Shore is a primary care provider, practicing in Internal Medicine in Ann Arbor, Michigan. Dr. Shore is rated as an Experienced provider by MediFind in the treatment of Megalencephalic Leukoencephalopathy with Subcortical Cysts. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypothyroidism.